Log in to save to my catalogue

Assessment of the Novel Anti-Seizure Potential of Validamycin A Using Zebrafish Epilepsy Model

Assessment of the Novel Anti-Seizure Potential of Validamycin A Using Zebrafish Epilepsy Model

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31a4943b868241619dd5635b000bbc07

Assessment of the Novel Anti-Seizure Potential of Validamycin A Using Zebrafish Epilepsy Model

About this item

Full title

Assessment of the Novel Anti-Seizure Potential of Validamycin A Using Zebrafish Epilepsy Model

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2024-06, Vol.29 (11), p.2572

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Epilepsy is a prevalent neurological disorder characterized by recurrent seizures. Validamycin A (VA) is an antibiotic fungicide that inhibits trehalase activity and is widely used for crop protection in agriculture. In this study, we identified a novel function of VA as a potential anti-seizure medication in a zebrafish epilepsy model. Electroence...

Alternative Titles

Full title

Assessment of the Novel Anti-Seizure Potential of Validamycin A Using Zebrafish Epilepsy Model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_31a4943b868241619dd5635b000bbc07

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31a4943b868241619dd5635b000bbc07

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules29112572

How to access this item